Literature DB >> 2075622

Is permanent contraception acceptable in sub-Saharan Africa?

J C Dwyer1, J M Haws.   

Abstract

Some authors contend that the low use of family planning in sub-Saharan Africa is due to a low demand for fertility regulation among African men and women. The present authors' experience in Africa has been that it is not the demand for family planning services, but the way services are delivered that accounts for low numbers of acceptors in Africa. The specific case of Kenya is mentioned, where improvements in the quality of sterilization services and increases in the number of institutions that can provide minilaparotomy under local anesthesia have led to an increase in the acceptance of sterilization. The authors maintain that the demand for all family planning methods does exist, and it is up to the donor agencies and family planning service providers to try to meet that demand by providing services that are efficient to providers while oriented to the clients' needs. In the case of voluntary surgical contraception, that means providing minilaparotomy under local anesthesia.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Behavior; Contraception; Contraceptive Usage; Culture; Developing Countries; Eastern Africa; Economic Factors; English Speaking Africa; Family Planning; Family Planning Programs; Female Sterilization; Health Services Evaluation; Kenya; Male Sterilization; Method Acceptability; Minilaparotomy; Motivation; Needs; Organization And Administration; Program Accessibility; Program Evaluation; Programs; Psychological Factors; Quality Of Health Care; Sterilization, Sexual; Tubal Ligation; Tubal Occlusion

Mesh:

Year:  1990        PMID: 2075622

Source DB:  PubMed          Journal:  Stud Fam Plann        ISSN: 0039-3665


  1 in total

1.  Desire for female sterilization among women wishing to limit births in rural Rakai, Uganda.

Authors:  Tom Lutalo; Ron Gray; Sanyukta Mathur; Maria Wawer; David Guwatudde; John Santelli; Fred Nalugoda; Fredrick Makumbi
Journal:  Contraception       Date:  2015-07-29       Impact factor: 3.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.